CureVac files for Nasdaq IPO to fund COVID-19 vaccine development
CureVac files to raise upward of $200 million in Nasdaq IPO to fund clinical development of COVID-19 vaccine.
Archives for August 13, 2020
Moderna lands US COVID-19 vaccine contract worth up to $8bn
US government inks deal to buy 100 million COVID-19 vaccine doses from Moderna for $1.5 billion, with more to follow.
Ligand inks $438m Pfenex buyout to add protein expression tech to portfolio
Ligand Pharmaceuticals strikes deal to buy Pfenex for $438 million upfront in cash to gain control of protein expression technology.